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| INTRODUC TI ON
"MELAS" is frequent among mitochondrial syndromes. It is an acronym for Mitochondrial Encephalomyopathy, Lactic Acidosis, and at least one Stroke-like episode. In about 80% of patients, it is caused by a maternally transmitted mutation m.3243A>G in the mitochondrial tRNA leucine 1 (MT-TL1). 1, 2 The highest prevalence of the "MELAS" mutation (m.3243A>G) is estimated to be 7.59 per 100 000 persons in northeast England, 16.3 per 100 000 in northern Finland, and 236 per 100 000 in Australia. So far, no correlation to ethnic origin has been described.
2
Apart from the classical "MELAS" syndrome, other phenotypic variants of the mitochondrial DNA mutation m.3243A>G have been reported. These include "MELAS"-similar encephalomyopathy, but without stroke-like episodes, or maternally inherited diabetes and deafness, and others-without central nervous system (CNS) involvement. [3] [4] [5] Thus, patients carrying the m.3243A>G mutation in the MT-TL1 do not always meet all the criteria for MELAS.
The proportion of normal and mutated DNA copies in the mitochondrion may vary among cells (heteroplasmy) and organs.
1 A large amount of mutant mitochondrial DNA is found in the skeletal muscle and other organs like heart, kidney or liver.
This article focuses especially on cardiac involvement and different progression of cardiac disease in children, adolescents, and adults affected by the m.3243A>G mutation.
| PATIENTS
We followed nine patients with the m.3243A>G mitochondrial mutation and particularly focused on myocardial involvement. We also describe additional symptoms and biochemical findings as well as patient outcomes (Table 1) :
Patient 1 was born at 38 weeks gestational age by primary Caesarean section. His 33-year-old mother had a history of three miscarriages and two cesarean deliveries. This pregnancy was uncomplicated. Birth weight was 2.395 kg (<3rd percentile), vertexbreech length 46 cm (<3rd percentile) and head circumference 32 cm (<3rd percentile). His mother is small-sized (as well as his sister) and suffers from a hearing impairment.
A few hours after birth, tachypnea and spasmodic strictures were (Figure 1 ). Over the next months, the girl progressively suffered from heart failure including muscular weakness and exercise intolerance. When she was 14 years of age, listing for heart transplantation was considered but abandoned because of malnutrition (poor general condition).
Stabilization was achieved to a large extent with oral furosemide, spironolactone, and phosphodiesterase inhibitors.
Motor and intellectual development were normal during infancy.
There was no family history of neurological disease. At the age of 14 she is 130 cm tall and has a body weight of 15.7 kg, both below the 3rd percentile, whereas head circumference at 54 cm is normal (50th percentile).
Laboratory investigations showed elevated concentrations of L lactate (up to 3.69 mmol/L); pyruvate was within the reference values. Kidney, liver, and heart parameters were elevated (Table 3) .
Patient 3 is a 23-year-old woman, who was first seen at the tertiary hospital when she underwent magnetic resonance imaging (MRI) because of delayed milestones at age 10 years. She began to sit without help at age 9 months. She started walking and spoke her first words at the age of 2 years, but presented with moderate ataxia and muscular hypotonia. Divergent strabismus was diagnosed when she was 1 year old. The MRI showed hypoplasia of the cerebellar vermis.
At the age of 13 years she was diagnosed with hypertrophic cardiomyopathy and severe mitral and tricuspid regurgitation. Short PR intervals (0.09°seconds) and delta waves on ECG were consistent with WPW syndrome. Over the last years, the patient progressively suffered from muscular weakness and exercise intolerance. She presented with sensorineural hearing loss since the age of 20 and has worn hearing aid devices since age 21. The m.3243A>G mutation was detected in her mother and her maternal uncle. Both also suffer from sensorineural hearing loss, are small-sized and have cardiomyopathy.
Now at the age of 23 she is 137 cm tall, weighs 41 kg and has a head circumference of 51 cm.
Laboratory investigations show large concentrations of L lactate;
pyruvate was not elevated. Kidney, liver, and heart parameters are normal (Table 3 ). She has suffered no strokes or stroke-like episodes.
Patient 4 is a 24-year-old male. Onset of symptoms was at age (Table 2 ), pointing to a Complex I deficiency in the muscle, which was later confirmed in individual enzyme measurements.
Transthoracic echocardiography showed no cardiac involvement, only minimal mitral regurgitation, and no cardiomyopathy.
There is no family history of neurological disease. Now at the age of 24 he is around 160 cm tall and weighs 51.7 kg.
High concentrations of L lactate and pyruvate were a constant finding. Kidney, liver, and heart parameters were intermittently elevated (Table 3) . She developed normally in childhood and adolescence until age 36. She is 160 cm tall and weighs 50.5 kg. Her head circumference is normal (55 cm). While her family history is uneventful, her mother was also small-sized, but showed no other symptoms.
L lactate was elevated. Kidney, liver, and heart parameters were also intermittently elevated before and after transplant (Table 3) .
m.3243A>G was found in blood (29%), urine (73%), kidney (89%), and oral mucosa (52% Kidney, liver, and heart parameters have been mildly elevated intermittently (Table 3) Over the last year, the patient progressively suffered from muscular weakness and exercise intolerance.
Laboratory investigations were done; beside elevated heart parameters, no other specific findings (especially concerning kidney or liver) were detected (Table 3) . She has suffered no strokes or strokelike episodes.
Patient 9 is a 68-year-old man, who developed normally until age 52 years. An audiogram showed a sensorineural hearing loss on both sides, whereas the patient complains only about left-sided hypoacusis. He has suffered from diabetes mellitus since age 52 and has taken insulin for the last 10 years. The patient is 165 cm tall and weighs 68 kg. His head circumference is normal (56 cm).
In the last four years, he has reported exercise intolerance without muscle pain. He was first seen at the tertiary hospital when he underwent exercise testing. Blood pressure and heart frequency during exercise showed normal elevations, whereas maximal work capacity was reduced to 56% (75 Watt; normal 133 Watt).
Intermittent premature supra-and ventricular contractions were His mother died at age 62 due to sudden cardiac death, but showed no other symptoms.
Kidney and heart parameters have been mildly elevated intermittently (Table 3) .
| D ISCUSS I ON
To As not all phenotypes associated with m.3234A>G meet all criteria for MELAS, we propose that the underlying disease be called "mito-
chondrial disease with underlying m.3243A>G mutation."
Heteroplasmy-the presence of normal and mutant mtDNA within the same cell population-causes the different cardiac phenotypes in patients. 7 Roach et al 8 listed the clinical symptoms in 110 patients carrying the m.3243A>G mutation and found WPW syndrome in 14% and congestive heart failure in 18%. In our small cohort, three of the nine patients (at the focus of this publication) To date there is no cure for these mitochondrial diseases, but in addition to receiving symptomatic treatment for their sensorineural hearing loss, heart insufficiency and diabetes mellitus, all eight patients are being treated with 2-8 mg/kg to a maximum of 600 mg coenzyme Q10, 50-400 mg riboflavin and 10-100 mg/kg to a maximum of 1000 mg L carnitine per day. neurological symptoms, especially in the acute phase. [10] [11] [12] [13] [14] In patients with progressive cardiomyopathy heart transplantation is only rarely an option, 15 but should be discussed in detail and can lead to a successful outcome. Furthermore, for this mutation family testing is recommended because cardiomyopathy due to mitochondrial disorders is maternally transmitted, whereas "the" classical cardiomyopathy follows an autosomal dominant pattern (all first-degree relatives at 50% risk).
| CON CLUS ION
To date there is no cure for these mitochondrial diseases, but some patients may benefit from coenzyme Q10 and riboflavin. In particular, the use of L arginine in patients with stroke-like episodes might be advantageous. [10] [11] [12] [13] [14] 
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